Member Info for 46Gillingham

Willswag

I asked this because I remenmber a number of yesrs ago one of the anailsts or brokers published a revenue forecast for QED based on both power and shipping and it was pritty enlighten on just how quickly revenue can grow....Be good to start getting regular forecasts...come on June

Do you have any forecast on Revenue for 2026 and beyond that can be shared?

The Company has internal forecasts, but as a pre-revenue Company has not been able to share these publicly. Given our recent revenues we are currently in discussions with brokers with regard to forecasts and hope to be able to publish before our 30 June year end.

Https://www.investormeetcompany.com/meetings/interim-results-435

The MSC trial, will QED get rayalties on the fuel used

Quadrise will be remunerated under the Tolling Agreement with Cargill for the trial.

Licella has secured an $8 million grant from the Australian Renewable Energy Agency (ARENA) to advance feasibility studies for a sustainable aviation fuel (SAF) biorefinery in the Bundaberg region of Queensland.Mar 6, 2025

Nice also well funded

Https://www.shell.com/business-customers/catalysts-technologies/resources-library/shell-catalysts-licella-low-carbon-aviation-fuel.html?utm_campaign=%5BLISP%5D%20LinkedIn%20Showcase%20Page%20Posts&utm_source=linkedin&utm_medium=social&utm_content=Shell%20Catalysts%20%26%20Technologies%20and%20Licella%20collaboration%20article

Trial start and finish in Q2 ....We hope!

Now expected to start mid May

TechyRob

Ive not seen 150m shares sold through the market in the last couple of months have you?

Im sure the II which invested at 3p will be very happy

Hotfinance must be the most positive RNS ive seen from QED in a longtime?

Sorry noon

What a lovely birthday present for me an Investor call at 9am :)

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 25 March 2025 at 09:00 GMT, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Quadrise via: https://www.investormeetcompany.com/quadrise-plc/register-investor

Investors who already follow Quadrise on the Investor Meet Company platform will automatically be invited.

Agree Hotfinance great news the samples for Utah have been shipped finally

Energy economics, environmental concerns, and tightening emissions regulations continue to drive the case for the adoption of MSAR® and bioMSAR™ fuels. With the International Maritime Organization ('IMO') expected to mandate lower greenhouse gas ('GHG') intensity fuels and to introduce a global maritime emissions pricing mechanism to achieve net-zero by 2050, Quadrise is well placed to capitalise. The Company's drop-in fuel solutions enable existing fleets and thermal energy systems to decarbonise with minimal investment, extending asset life while cutting costs and emissions.

The remainder of calendar year 2025 is set to be an important period for Quadrise, with the installation and commissioning of trial equipment at MAC² paving the way for operational vessel trials with MSC and Cargill aboard the MSC Leandra V as a precursor to the conclusion of commercial agreements.

Meanwhile, the commercial trial at OCP's Jorf Lasfar site and the MAN diesel engine trial at Sparkle Power in Panama are both planned to commence before the financial year-end with each expected to lead to a commercial supply contract upon success. Marketing efforts with low-sulphur, lower-carbon MSAR® are also expected to commence following the lab testing programme on Valkor's heavy sweet oil samples, with equipment delivery to Utah after the Sparkle trial to enable supply to potential clients.

With strong market fundamentals, tightening regulations, and growing end-user demand for cost-effective decarbonization solutions, the business case for MSAR® and bioMSAR™ has never been stronger.

Quadrise Plc (AIM: QED), the transition technology provider for a cleaner planet, announces its unaudited interim results for the six months ended 31 December 2024 ("H2 2024") and provides an update on developments during the first quarter of 2025.

Chairman Andy Morrison, CEO Jason Miles and CFO David Scott will provide a live presentation relating to the interim results via the Investor Meet Company platform on 25 March 2025 at 12:00 noon GMT - registration details are outlined below.

FINANCIAL SUMMARY

· £6.5 million (before costs) raised in January 2025 through a successful placing and retail offer, increasing cash reserves to £7.1 million at 28 February 2025 (31 December 2024: £1.4 million, 31 December 2023: £1.7 million).

· H2 2024 loss after tax of £1.7 million (H2 2023: £1.7 million). This includes production and development costs of £0.8 million (H2 2023: £0.9 million) and administration expenses of £0.9 million (H2 2023: £0.7 million).

· Total assets of £5.2 million at 31 December 2024 (31 December 2023: £5.4 million).

BUSINESS SUMMARY

The Company's strategy is to generate demand within the shipping industry and other sectors, while stimulating the supply of its fuels around global marine bunkering hubs. The Company's projects are designed to fulfil this strategy, with progress in each of these during the period outlined as follows:

Decarbonisation of shipping: MSC

· In November 2024, a Collaboration and Operational Trial Agreement was signed with MSC and Cargill, committing the parties to complete trials on board an MSC vessel to obtain a Letter of No Objection ('LONO') from engine manufacturer Wärtsilä upon success.

· Work is now well underway to prepare the Quadrise trial equipment ahead of installation and commissioning at the MAC² terminal in Antwerp, Belgium in Q2 2025. In parallel, bilateral agreements between Quadrise, and Cargill and MAC² respectively, are expected to be concluded soon.

· The operational trial is planned to commence in Q2 2025. It will comprise an initial Proof of Concept period using MSAR® and then bioMSAR™ for performance baseline tests, followed by 4,000 hours of operation (approximately 6-8 months) on bioMSAR™ in order to obtain the LONO.

Supporting projects: Establishing a global supply network

· Morocco: Preparations are underway for a commercial MSAR® trial at a new site location at OCP's Jorf Lasfar facility, planned to commence in Q2 2025. OCP and Quadrise are also exploring new fuel applications at other OCP sites. The OCP Letter of Intent is facilitating Quadrise discussions with potential MSAR® suppliers upon successful trial completion at Jorf Lasfar.

· Central America: A Material Transfer and Trial Agreement was signed in December 2024 with Sparkle Power SA in Panama, to trial MSAR® and bioMSAR™ at their 50MW El Giral power plant. Preparations are now underway for the Q2 2025 trial, with a success

Im more hopeful on Panama coming good within the next few months. I think MSC and Cargill will happen however its on their timetable. Jason also said he was hopeful that MSC would start using MSAR from the summer onwards in the Med this could be interesting if it happens.

I will be disapointed if the share Price is not over 10p by the year end

Hotfinance should panama happen which would be fantastic.

Do you think KSA may revisit working with QED?

Im now off to Gatwick for a week in the sun. Will be keen to see the interims on Monday should they be published.....

I hope that their will be positive news while readying myself for extended timelines.....Either way 2025 should be a game changer for QED....Stay positive the future looks wonderful

Hotfinance I agree with your post with the lack of any update I think its both balanced and how we should be thinking on current projects However it will be lovely to be surprised on the interims with better news on how any of the projects have moved forward.

What are your thoughts on Material Transfer and Trial Agreement with Sparkle Power SA, Panama?